US2005271743A1PendingUtilityA1

Treatment of inflammatory skin conditions

59
Assignee: BURRELL ROBERT EPriority: Apr 23, 2001Filed: Jul 1, 2005Published: Dec 8, 2005
Est. expiryApr 23, 2021(expired)· nominal 20-yr term from priority
Inventors:Robert Edward BurrellHua Yin
A61P 9/00A61P 43/00A61P 29/00A61P 27/16A61P 35/00A61P 31/04A61P 31/10A61P 31/00A61K 9/14Y10T428/31855A61K 9/0024A61L 29/10A61P 1/02A61L 27/30A61P 1/00A61P 17/02A61L 15/46A61P 17/10A61K 9/0019A61P 17/06A61L 2300/104A61K 47/34A61P 17/00A61K 33/38A61L 2300/404A61K 9/0075A61L 2300/102A61L 17/145A61P 19/02A61P 17/04A61K 47/38A61L 31/082A61K 9/0078A61L 2300/452A61P 11/04A61P 11/00A61P 15/00A61K 9/7007A61P 11/02A61L 2300/63A61K 33/40A61P 13/08A61P 13/00A61P 17/08Y10S424/15A61L 2300/624A61L 2300/606A61P 19/00A01N 59/16A61K 33/243A61K 33/242A61K 33/24
59
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention relates to the use of one or more antimicrobial metals, most preferably silver, preferably formed with atomic disorder, and preferably in a nanocrystalline form, for the treatment of inflammatory skin conditions. The nanocrystalline antimicrobial metal of choice may be used in the form of a nanocrystalline coating of one or more antimicrobial metals, a nanocrystalline powder of one or more antimicrobial metals, or a solution containing dissolved species from a nanocrystalline powder or coating of one or more antimicrobial metals.

Claims

exact text as granted — not AI-modified
1 . A method of reducing inflammation of an inflammatory skin condition which comprises: 
 contacting a problem area of a patient, with a therapeutically effective amount of one or more antimicrobial metals in a crystalline form to provide a localized anti-inflammatory effect, wherein the one or more antimicrobial metals are characterized by sufficient atomic disorder, such that the metal, in contact with an alcohol or water-based electrolyte, releases atoms, ions, molecules, or clusters of at least one antimicrobial metal at a concentration sufficient to provide a localized anti-inflammatory effect.    
     
     
         2 - 94 . (canceled)

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.